John Bothos

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

Martin Dreyling, Wojciech Jurczak, Mats Jerkeman et al. · The Lancet · 2015 · 462 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Human LATS1 Is a Mitotic Exit Network Kinase

John Bothos, Robyn L. Tuttle, Michelle Ottey et al. · Cancer Research · 2005 · 123 citations

Life Sciences, Cell Biology, Molecular Biology +14

The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form Lys63-linked polyubiquitin chains

John Bothos, Matthew K. Summers, Monica Venere et al. · Oncogene · 2003 · 92 citations

Life Sciences, Biochemistry, Molecular Biology +13

Crystal Structure of a Human Mob1 Protein

Elena S. Stavridi, Kimberly G. Harris, Yentram Huyen et al. · Structure · 2003 · 78 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid Malignancies

Ravi Salgia, Premal H. Patel, John Bothos et al. · Clinical Cancer Research · 2014 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17